These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27313122)

  • 41. Testosterone treatment in the aging male: myth or reality?
    Nigro N; Christ-Crain M
    Swiss Med Wkly; 2012; 142():w13539. PubMed ID: 22430839
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Testosterone administration in older men.
    Matsumoto AM
    Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Testosterone replacement therapy: who to evaluate, what to use, how to follow, and who is at risk?
    Afiadata A; Ellsworth P
    Hosp Pract (1995); 2014 Dec; 42(5):69-82. PubMed ID: 25485919
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Testosterone deficiency as a risk factor for cardiovascular disease.
    Ullah MI; Washington T; Kazi M; Tamanna S; Koch CA
    Horm Metab Res; 2011 Mar; 43(3):153-64. PubMed ID: 21283952
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prostate-specific antigen (PSA) concentrations in hypogonadal men during 6 years of transdermal testosterone treatment.
    Raynaud JP; Gardette J; Rollet J; Legros JJ
    BJU Int; 2013 May; 111(6):880-90. PubMed ID: 23294726
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Testosterone deficit syndrome in the old male].
    Chantada Abal V; Vázquez-Martul Pazos D; Portela Pereira P; Aller Rodriguez M; Barreiro Mallo A; Sánchez Vázquez A
    Arch Esp Urol; 2013 Sep; 66(7):684-8. PubMed ID: 24047627
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report.
    Morrison BF; Reid M; Madden W; Burnett AL
    Andrology; 2013 Jul; 1(4):576-82. PubMed ID: 23606509
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endocrine aspects of male sexual dysfunctions.
    Buvat J; Maggi M; Gooren L; Guay AT; Kaufman J; Morgentaler A; Schulman C; Tan HM; Torres LO; Yassin A; Zitzmann M
    J Sex Med; 2010 Apr; 7(4 Pt 2):1627-56. PubMed ID: 20388162
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
    Miner M; Canty DJ; Shabsigh R
    Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risks of testosterone-replacement therapy and recommendations for monitoring.
    Rhoden EL; Morgentaler A
    N Engl J Med; 2004 Jan; 350(5):482-92. PubMed ID: 14749457
    [No Abstract]   [Full Text] [Related]  

  • 51. Pratical aspects of testosterone substitution.
    Wang C; Swerdloff RS
    J Endocrinol Invest; 2005; 28(3 Suppl):109-11. PubMed ID: 16042368
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.
    Debruyne FM; Behre HM; Roehrborn CG; Maggi M; Wu FC; Schröder FH; Jones TH; Porst H; Hackett G; Wheaton OA; Martin-Morales A; Meuleman E; Cunningham GR; Divan HA; Rosen RC;
    BJU Int; 2017 Feb; 119(2):216-224. PubMed ID: 27409523
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of testosterone therapy in adolescents and young men with hypogonadism: are we following adult clinical practice guidelines?
    Nahata L; Yu RN; Bhasin S; Cohen LE
    J Pediatr Endocrinol Metab; 2015 May; 28(5-6):635-40. PubMed ID: 25324443
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Andropause and testosterone deficiency: how to treat in 2012?].
    Renneboog B
    Rev Med Brux; 2012 Sep; 33(4):443-9. PubMed ID: 23091954
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Late-Onset Hypogonadism and Testosterone Replacement in Older Men.
    Bhattacharya RK; Bhattacharya SB
    Clin Geriatr Med; 2015 Nov; 31(4):631-44. PubMed ID: 26476121
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Testosterone deficiency and risk factors in the metabolic syndrome: implications for erectile dysfunction.
    Guay AT; Traish A
    Urol Clin North Am; 2011 May; 38(2):175-83. PubMed ID: 21621084
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Testosterone: a hormone preventing cardiovascular disease or a therapy increasing cardiovascular events?
    Gencer B; Mach F
    Eur Heart J; 2016 Dec; 37(48):3569-3575. PubMed ID: 26637832
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Testosterone deficiency and replacement.
    Howell S; Shalet S
    Horm Res; 2001; 56 Suppl 1():86-92. PubMed ID: 11786693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Therapy of the "aging male"].
    Diemer T; Hauck EW; Rohde V; Weidner W
    Urologe A; 2005 Oct; 44(10):1173-8. PubMed ID: 16151757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.